Human SPARC-like 1/SPARCL1 Biotinylated Antibody

Catalog #: BAF2728
2 Citations Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
BAF2728

Product Details

Citations (2)

Supplemental Products

Reviews

Summary Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human SPARC-like 1/SPARCL1 Biotinylated Antibody Summary

Species Reactivity

Human

Specificity

Detects human SPARC‑like 1/SPARCL1 in Western blots.

Source

Polyclonal Goat IgG

Purification

Antigen Affinity-purified

Immunogen

Mouse myeloma cell line NS0-derived recombinant human SPARC‑like 1/SPARCL1
Ile17-Phe664
Accession # AAH33721

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.

Label

Biotin

Applications

Recommended Concentration

Sample

Western Blot

0.1 µg/mL

Recombinant Human SPARC-like 1/SPARCL1 (Catalog # 2728-SL)

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Reconstitution Calculator

Preparation and Storage

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS.

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: SPARC-like 1/SPARCL1

SPARCL1 (Secreted Protein, Acidic and Rich in Cysteines‑like 1), also known as hevin, SC1 or MAST9, is a member of the SPARC family of extracellular glycoproteins (1, 2). SPARCL1 is an anti‑adhesive protein that is widely expressed in tissues such as brain, heart, lung, muscle and kidney, but not liver (3, 4). Human SPARCL1 contains a 16 amino acid (aa) signal sequence and a 648 aa mature region with four domains: a 416 aa N‑terminal acidic region, a 23 aa follistatin‑like domain, a 55 aa kazal‑like segment and a 48 aa EF‑hand/calcium‑binding domain (3, 4). SPARCL1 is predicted at 75 kDa, but migrates at ~130 kDa, which has been explained either by disulfide‑linked homodimerization or by glycosylation and high acidity (3‑5). Some truncated forms have been reported. In mouse, a 55 kDa C‑terminal fragment is the only form in kidney and represents a portion of SPARCL1 in other tissues (6). In humans, a 25 kDa form is increased in liver tumors that are encapsulated, while the full‑length form is down‑regulated in many epithelial cell‑derived tumors (7, 8). SPARCL1 inhibits adhesion and spreading on a variety of substrates (5, 9). It is thought to cause antiadhesive signaling that terminates neuronal migration, consistent with production by glial and neuronal cells during development or in response to trauma (10). In tonsillar high endothelial venules (HEV), SPARCL1 may induce endothelial cell dissociation, promoting extravasation (3). SPARCL1 binds collagen; in mice, deletion causes dermal collagen fibrils that are smaller in diameter and deficient in decorin (6, 11). Human mature SPARCL1 shares 67%, 69%, 78%, 76%, 72% and 72% aa identity with mouse, rat, equine, canine, porcine and bovine SPARCL1, respectively. The follistatin‑like, kazal-like and calcium-binding domains of SPARCL1 show 61% aa identity with corresponding regions of SPARC.

References

Framson, P. E. and E. H. Sage (2004) J. Cell. Biochem. 92:679.
Sullivan, M. M. and E. H. Sage (2004) Int. J. Biochem. Cell Biol. 36:991.
Girard, J. P. and T. A. Springer (1995) Immunity 2:113.
Bendik, I. et al. (1998) Cancer Res. 58:626.
Brekken, R. A. et al. (2004) J. Histochem. Cytochem. 52:735.
Hambrock, H. O. et al. (2003) J. Biol. Chem. 278:11351.
Lau, C. P. et al. (2006) J. Pathol. 210:469.
Isler, S. G. et al. (2001) Int. J. Oncol. 18:521.
Girard, J. P. and T. A. Springer (1996) J. Biol. Chem. 271:4511.
Gongidi, V. et al. (2004) Neuron 41:57.
Sullivan, M. M. et al. (2006) J. Biol. Chem. 281:27621.

Entrez Gene IDs

8404 (Human); 13602 (Mouse)

Alternate Names

Hevin; High endothelial venule protein; MAST 9; MAST9; PIG33; proliferation-inducing protein 33; SC1; SPARC like 1; SPARCL1; SPARC-like 1 (hevin); SPARC-like 1 (mast9, hevin); SPARC-like 1; SPARC-like protein 1

Product Datasheets

Product Datasheet

COA

SDS

Related Research Areas

Citations for Human SPARC-like 1/SPARCL1 Biotinylated Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

2 Citations: Showing 1 - 2
Filter your results:

Filter by: